Sold out

Formulation and Evaluation of Colon Targeted Aceclofenac Tablet - Targeted drug delivery system

English · Paperback / Softback

Description

Read more

The aim of the study was to develop and evaluate enteric coated matrix tablet of Aceclofenac for colonic delivery by exploiting prolonged release characteristics of HPMC K4M with pH dependent solubility property of a Eudragit S100. Extended release matrix tablet were prepared by direct compression of hydrophilic polymer HPMC and other ingredients. The pH dependent release was achieved by coating matrix tablet with Eudragit S100, soluble at pH 7. All the formulations of 32 factorial design (A1- A9) were evaluated for the physicochemical parameters and subjected to in vitro drug release in 0.1 N HCl for two hour, three hour in pH 5.2 Phosphate buffer then in pH 7.4 phosphate buffer up to 17 hrs. Multiple regression analysis, two way ANOVA followed by Tukey test were performed. Polynomial equations and response surface plots were generated for all dependent variables. It was observed that both the factors had significant effect on dependable variables (Q6, Q12, Q17 and n, k). The formulation A5 was most likely to provide targeting of aceclofenac in the colon owing to its minimal release of the drug in the first 5 hr and give release up to 17hr with 62.21 similarity factor.

Product details

Authors Ashish Patel, Ashish V. Patel, Mukesh Patel, Mukesh R Patel, Natubhai Patel
Publisher LAP Lambert Academic Publishing
 
Languages English
Product format Paperback / Softback
Released 19.06.2012
 
EAN 9783659150982
ISBN 978-3-659-15098-2
No. of pages 116
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.